Cancer
UroToday: Nuclear NADPH oxidase-4 associated with disease progression In renal cell carcinoma
June 12, 2020
UT Health San Antonio researchers confirmed the role of a certain protein in the development of high-grade kidney cancer. Their findings were recently published in the journal, Translational Research. Dr. Dharam Kaushik, Department of Urology, is the lead and corresponding author, Dr. Ronald Rodriguez, Department of Urology, is senior author. A total of 14 faculty […]
Voelcker Fund awards $650,000 to cancer researchers on the rise
June 9, 2020
The Max and Minnie Tomerlin Voelcker Fund supports innovative cancer research projects conducted by rising star faculty members.
Mays Cancer Center launches new website
June 9, 2020
The Mays Cancer Center has launched a new website that will improve access to information and clarify services offered in patient care and research.
BrightSurf.com: UT Health San Antonio study shows Nox4 protein may predict untreatable kidney cancer
June 5, 2020
A team of researchers confirmed the role of a certain protein in the development of high-grade kidney cancer. The researchers showed that a higher level of the protein can be used as a marker to predict which tumors will develop treatment resistance and progress more rapidly. Dharam Kaushik, MD, associate professor of urology, led the […]
All My Medicine.com: Study shows Nox4 protein may predict untreatable kidney cancer
June 5, 2020
A team of researchers confirmed the role of a certain protein in the development of high-grade kidney cancer. The researchers showed that a higher level of the protein can be used as a marker to predict which tumors will develop treatment resistance and progress more rapidly. Dharam Kaushik, MD, associate professor of urology, led the […]
News Break.com: Study shows Nox4 protein may predict untreatable kidney cancer
June 5, 2020
A team of researchers confirmed the role of a certain protein in the development of high-grade kidney cancer. The researchers showed that a higher level of the protein can be used as a marker to predict which tumors will develop treatment resistance and progress more rapidly. Dharam Kaushik, MD, associate professor of urology, led the […]